Replies to post #573001 on ORIONS Money Stocks

[TheFinalCD]

https://finviz.com/quote.ashx?t=ARDS&ty=c&ta=1&p=d

Message in reply to:
(ARDS) $0.84 --BIG Phase 3 data in December ...Very low valuation of $17 million ,,positive results could push this stock toward $5


Closed enrollment in the Company’s Phase 3 study evaluating AR-301 for the treatment of Ventilator Associated Pneumonia (VAP). Aridis expects to report top-line data from this study in December 2022.